Autolus therapeutics plc (AUTL)
CashFlow / Yearly
Sep'18Sep'17Sep'16
Cash flows from operating activities:
Net loss

-44,751

-19,727

-12,550

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

1,709

1,009

478

Loss on disposal of fixed assets

-8

0

0

Non-cash share-based compensation

6,765

3,153

2,257

Non-cash consideration for licenses

0

0

1,199

Changes in operating assets and liabilities
Prepaid expenses and other current assets

7,132

2,317

2,048

Accounts payable

838

434

507

Accrued expenses and other liabilities

11,026

1,088

308

Net cash used in operating activities

-31,537

-16,360

-9,849

Cash flows from investing activities:
Purchases of property and equipment

9,119

2,876

1,855

Purchase of intangible assets

412

0

0

Net cash used in investing activities

-9,531

-2,876

-1,855

Cash flows from financing activities:
Proceeds of issuance of ordinary shares, net of issuance costs

156,920

127,686

32,222

Net cash provided by financing activities

156,920

127,686

32,222

Effect of exchange rate changes on cash

-5,833

561

-2,662

Net increase in cash

110,019

109,011

17,856

Supplemental Cash Flow Information
Property and equipment purchases included in accounts payable

328

0

0